NGM
Ngm Biopharmaceuticals Inc
Column Group L P bought $1.9M of Ngm Biopharmaceuticals Inc
Director and 10% owner
Bought$1,902,032
$11.43Price
166,350Shares
+1%Stake
What NGM did for a copier
Prices for NGM after this filing aren't in yet.
Column Group L P's record
5 other buys with 3 months of prices since 2016: on average −28.4% against the S&P 500, and 0 of 5 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, May 11. Filed Fri, May 13. Not investment advice.